{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:28:44Z","timestamp":1778858924995,"version":"3.51.4"},"reference-count":156,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["11012546, 14254520, 16954531"],"award-info":[{"award-number":["11012546, 14254520, 16954531"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Central and peripheral tolerance are key to maintain immune homeostasis. Imbalance of these processes often leads to diseases such as allergy, cancer or autoimmune disorders. During the immune response to allergens, several regulatory immune cells play a role in the development of peripheral tolerance and maintenance of homeostasis by inhibiting the development of CD4<jats:sup>+<\/jats:sup> type 2 helper T cells, impairing the production of pro-allergenic cytokines, reducing the activation of effector cells driving allergic inflammation and generating allergen-neutralizing antibodies. However, the precise mechanisms of how peripheral immune tolerance is effectively maintained in healthy people, but not in allergic patients are still not well understood. Immune checkpoints have recently been proposed as critical molecular pathways across diseases for understanding how the immune system maintains homeostasis in many pathologies such as cancer, type 1 diabetes, multiple sclerosis, Crohn\u2019s disease and allergy, among others. Particularly in the context of allergy, in-depth studies on immune checkpoint pathways might lead to emerging therapeutic targets. Tumor necrosis factor receptor 2 (TNFR2) is a crucial protein involved in promotion, expansion and maintenance of immune tolerance, being suggested as a key target for the treatment of several immune-based diseases including allergy. Here, we review the involvement of TNFR2 in allergic inflammation and allergen tolerance, its structural properties, signaling pathways, and importance for immune tolerance as a common mechanism, with the focus on possible implications for novel immunomodulatory treatments of allergic diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1613719","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:12:12Z","timestamp":1750306332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view"],"prefix":"10.3389","volume":"16","author":[{"given":"Guillem","family":"Montamat-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murilo Luiz","family":"Bazon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Demczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ollert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.0000000000000128","article-title":"Immunological mechanisms of tolerance: central, peripheral and the role of T and B cells","volume":"13","author":"Meng","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00253","article-title":"Peripheral and thymic foxp3+ Regulatory T cells in search of origin, distinction, and function","volume":"4","author":"Dhamne","year":"2013","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8512-5","article-title":"Regulatory T cells and their roles in immune dysregulation and allergy","volume":"58","author":"Pellerin","year":"2014","journal-title":"Immunologic Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.003","article-title":"Regulatory T cells in allergic diseases","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"Cd4+Cd25+ Regulatory T cells suppress mast cell degranulation and allergic responses through ox40-ox40l interaction","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4217","article-title":"Role of innate lymphoid cells in allergic diseases","volume":"40","author":"Pasha","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.03.015","article-title":"Roles of innate lymphoid cells (Ilcs) in allergic diseases: the 10-year anniversary for ilc2s","volume":"147","author":"Bartemes","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.107","article-title":"Regulatory ilcs don't rely on foxp3","volume":"17","author":"Bordon","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.006","article-title":"Role of regulatory B cells in immune tolerance to allergens and beyond","volume":"138","author":"van de Veen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.042","article-title":"Human regulatory B cells control the T(Fh) cell response","volume":"140","author":"Achour","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.05.008","article-title":"The emerging field of regulatory B cell immunometabolism","volume":"33","author":"Rosser","year":"2021","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000400","article-title":"The role of regulatory B cells in allergen immunotherapy","volume":"17","author":"Van De Veen","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2016.09.050","article-title":"Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans","volume":"167","author":"Bacher","year":"2016","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pai.13189","article-title":"Allergen immunotherapy in children user's guide eaaci allergen immunotherapy user's guide","volume":"31","author":"Alvaro-Lozano","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/J.JACI.2010.09.034\/ATTACHMENT\/2F47BF89-8591-4C6C-85E7-B18B37079C91\/MMC1.DOC","article-title":"Allergen immunotherapy: A practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2017.1334745","article-title":"Allergen-specific immunotherapy of hymenoptera Venom Allergy \u2013 Also a Matter of Diagnosis","volume":"13","author":"Schiener","year":"2017","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/all.15945","article-title":"Hot topics in allergen immunotherapy, 2023: current status and future perspective","volume":"79","author":"Zemelka-Wiacek","year":"2024","journal-title":"Allergy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"AB163","DOI":"10.1016\/j.jaci.2021.12.540","article-title":"Blocking the inhibitory receptor pd-1 prevents allergic immune response and anaphylaxis in mice","volume":"149","author":"Lama","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/J.1398-9995.2010.02458.X","article-title":"Role of pd-L1 and pd-L2 in allergic diseases and asthma","volume":"66","author":"Singh","year":"2011","journal-title":"Allergy"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12243-0","article-title":"Double negative T cells mediate lag3-dependent antigen-specific protection in allergic asthma","volume":"10","author":"Tian","year":"2019","journal-title":"Nat Commun 2019 10:1"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.200940282","article-title":"Ctla4-ig inhibits allergic airway inflammation by a novel cd28-independent, nitric oxide synthase-dependent mechanism","volume":"40","author":"Deppong","year":"2010","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt038","article-title":"Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in tnf-induced experimental metastasis","volume":"34","author":"Chopra","year":"2013","journal-title":"Carcinogenesis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3173","article-title":"Tnf receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases","volume":"75","author":"Ham","year":"2015","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.85632","article-title":"Tnfr2 and regulatory T cells: potential immune checkpoint target in cancer immunotherapy","volume-title":"Cytokines. IntechOpen","author":"He","year":"2020"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3394","article-title":"Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic tumor-associated macrophages","volume":"75","author":"Frankenberger","year":"2015","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0292-9","article-title":"Targeted killing of tnfr2-expressing tumor cells and tregs by tnfr2 antagonistic antibodies in advanced s\u00e9zary syndrome","volume":"33","author":"Torrey","year":"2019","journal-title":"Leukemia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.43","article-title":"Treg activation defect in type 1 diabetes: correction with tnfr2 agonism","volume":"5","author":"Okubo","year":"2016","journal-title":"Clin Trans Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1807499115","article-title":"Intrinsic tnfr2 signaling in T regulatory cells provides protection in cns autoimmunity","volume":"115","author":"Atretkhany","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200635921","article-title":"Transmembrane tnf protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity","volume":"36","author":"Alexopoulou","year":"2006","journal-title":"Eur J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.11.017","article-title":"Oligodendrocytes modulate the immune-inflammatory response in eae via tnfr2 signaling","volume":"84","author":"Madsen","year":"2020","journal-title":"Brain Behavior Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1373236","article-title":"Tnfr2: the new treg switch","volume":"7","author":"Cohen","year":"2018","journal-title":"OncoImmunology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093347","article-title":"The role of tnfr2 and dr3 in the in vivo expansion of tregs in T cell depleting transplantation regimens","volume":"21","author":"Rodriguez-Barbosa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502034","article-title":"Aging converts innate B1a cells into potent cd8+ T cell inducers","volume":"196","author":"Lee-Chang","year":"2016","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6180","article-title":"Tnf-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes","volume":"164","author":"Hornung","year":"2000","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.109","article-title":"Principles of antibody-mediated tnf receptor activation","volume":"22","author":"Wajant","year":"2015","journal-title":"Cell Death Differentiation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109972118","article-title":"Tnf plays a crucial role in inflammation by signaling via T cell tnfr2","volume":"118","author":"Alam","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-019-1938-x","article-title":"Tnfr2 induced priming of the inflammasome leads to a ripk1-dependent cell death in the absence of xiap","volume":"10","author":"Knop","year":"2019","journal-title":"Cell Death Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02572","article-title":"The key role of tnf-tnfr2 interactions in the modulation of allergic inflammation: A review","volume":"9","author":"Ahmad","year":"2018","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2017","article-title":"The tnf family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The tnf receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa844","article-title":"A systems-biology model of the tumor necrosis factor (Tnf) interactions with tnf receptor 1 and 2","volume":"37","author":"Prada","year":"2021","journal-title":"Bioinformatics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"ra83","DOI":"10.1126\/scisignal.2000954","article-title":"Solution of the structure of the tnf-tnfr2 complex","volume":"3","author":"Mukai","year":"2010","journal-title":"Sci Signaling"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.683946","article-title":"Binding studies of tnf receptor superfamily (Tnfrsf) receptors on intact cells","volume":"291","author":"Lang","year":"2016","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615141","article-title":"Receptor oligomerization and its relevance for signaling by receptors of the tumor necrosis factor receptor superfamily","volume":"8","author":"Kucka","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02040","article-title":"Targeting regulatory T cells by addressing tumor necrosis factor and its receptors in allogeneic hematopoietic cell transplantation and cancer","volume":"10","author":"Wajant","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (Tnf) receptor shedding controls thresholds of innate immune activation that balance opposing tnf functions in infectious and inflammatory diseases","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1266-6","article-title":"Differential roles of tnf\u03b1-tnfr1 and tnf\u03b1-tnfr2 in the differentiation and function of cd4 + Foxp3 + Induced treg cells in vitro and in vivo periphery in autoimmune diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12964-020-00564-3","article-title":"The tnf\/tnfr2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect","volume":"18","author":"Naserian","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1159\/000516352","article-title":"Ligand-regulated expression of tnf receptors 1 and 2 determines receptor-mediated functional responses","volume":"182","author":"Alshevskaya","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/J.CYTOGFR.2014.07.016","article-title":"Tnf and tnf-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth factor Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/FEBS.12419","article-title":"Lymphotoxin \u03b1 Induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor","volume":"280","author":"Etemadi","year":"2013","journal-title":"FEBS J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/AR3376\/FIGURES\/1","article-title":"Lymphotoxin \u03b1 Revisited: general features and implications in rheumatoid arthritis","volume":"13","author":"Calmon-Hamaty","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/J.CYTOGFR.2014.02.001","article-title":"Lymphotoxin and tnf: how it all began\u2014a tribute to the travelers","volume":"25","author":"Ruddle","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01675","article-title":"Forward and reverse signaling mediated by transmembrane tumor necrosis factor-alpha and tnf receptor 2: potential roles in an immunosuppressive tumor microenvironment","volume":"8","author":"Qu","year":"2017","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.CYTO.2016.08.027","article-title":"Tnfr signalling and its clinical implications","volume":"101","author":"Tseng","year":"2018","journal-title":"Cytokine"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.037341","article-title":"Membrane tumor necrosis factor (Tnf) induces P100 processing via tnf receptor-2 (Tnfr2)","volume":"285","author":"Rauert","year":"2010","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting nf-\u03bab pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/CR.2010.177","article-title":"Non-canonical nf-\u03bab signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical nf-\u03bab pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMED.2016.03.002","article-title":"Noncanonical nf-\u03bab signaling in health and disease","volume":"22","author":"Cildir","year":"2016","journal-title":"Trends Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585880","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","volume":"11","author":"Gough","year":"2020","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/J.IT.2004.03.008","article-title":"The two nf-\u03bab activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"Nf-\u03bab signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction Targeted Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMED.2007.09.002","article-title":"Signaling to nf-\u03bab by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/FIMMU.2014.00614\/BIBTEX","article-title":"Molecular mechanisms that influence the macrophage M1-M2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15254","article-title":"Critical roles of C-rel in autoimmune inflammation and helper T cell differentiation","volume":"110","author":"Hilliard","year":"2002","journal-title":"J Clin Invest"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20110462","article-title":"The th17 immune response is controlled by the rel\u2013ror\u03b3\u2013ror\u03b3t transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of nlrp3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann New York Acad Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and s\u00e9zary syndrome identifies recurrent alterations in tnfr2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-4-50","article-title":"The four types of tregs in Malignant lymphomas","volume":"4","author":"Wang","year":"2011","journal-title":"J Hematol Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03460.x","article-title":"The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on cd4+Foxp3+ Regulatory T cells","volume":"133","author":"Chen","year":"2011","journal-title":"Immunology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor \u03b1 Blockade exacerbates murine psoriasis-like disease by enhancing th17 function and decreasing expansion of treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000560","article-title":"Critical role for tnf in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells","volume":"185","author":"Kleijwegt","year":"2010","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00444","article-title":"Tumor necrosis factor \u03b1 and regulatory T cells in oncoimmunology","volume":"9","author":"Salomon","year":"2018","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500286","article-title":"Transmembrane tnf\u2013tnfr2 impairs th17 differentiation by promoting il2 expression","volume":"195","author":"Miller","year":"2015","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.783282\/BIBTEX","article-title":"Il-6 and tnf\u03b1 Drive extensive proliferation of human tregs without compromising their lineage stability or function","volume":"12","author":"Skartsis","year":"2021","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3389\/fimmu.2017.01951","article-title":"Expression of tumor necrosis factor receptor 2 characterizes tlr9-driven formation of interleukin-10-producing B cells","volume":"8","author":"Ticha","year":"2018","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.58.2.249","article-title":"Regulation of nk cells through the 80-kda tnfr (Cd120b)","volume":"58","author":"Mason","year":"1995","journal-title":"J Leukocyte Biol"},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.1997.tb52085.x","article-title":"Tumor necrosis factor (Tnf) enhances the locomotion of low-density human tonsillar B lymphocytes through the selective triggering of type ii receptor","volume-title":"B\u2010Lymphocytes and Autoimmunity","author":"Corcione","year":"1997"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.202048988","article-title":"Tnfr2 expression is a hallmark of human memory B cells with suppressive function","volume":"51","author":"Ticha","year":"2021","journal-title":"Eur J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1159\/000448077","article-title":"Tnf\u03b1 Augments cytokine-induced nk cell ifn\u03b3 Production through tnfr2","volume":"8","author":"Almishri","year":"2016","journal-title":"J Innate Immun"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1386826","article-title":"Tnfr2\/birc3-traf1 signaling pathway as a novel nk cell immune checkpoint in cancer","volume":"7","author":"Ivagn\u00e8s","year":"2018","journal-title":"OncoImmunology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-026385","article-title":"Essential role of the tnf-tnfr2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302929","article-title":"Dendritic cell maturation and survival are differentially regulated by tnfr1 and tnfr2","volume":"193","author":"Maney","year":"2014","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.9.4792","article-title":"Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for tnf receptor-1","volume":"165","author":"Funk","year":"2000","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-9-38","article-title":"Differential expression of tnfr1 (Cd120a) and tnfr2 (Cd120b) on subpopulations of human monocytes","volume":"9","author":"Hijdra","year":"2012","journal-title":"J Inflammation"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3HI0220-119RR","article-title":"Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell rna sequencing of monocytes","volume":"110","author":"Watanabe","year":"2021","journal-title":"J Leukocyte Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1079851","article-title":"Tnf- \u03b1 Autocrine feedback loops in human monocytes: the pro- and anti-inflammatory roles of the tnf- \u03b1 Receptors support the concept of selective tnfr1 blockade in vivo","volume":"2016","author":"Gane","year":"2016","journal-title":"J Immunol Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.19","article-title":"Myeloid suppressor cells require membrane tnfr2 expression for suppressive activity","volume":"2","author":"Polz","year":"2014","journal-title":"Immunity Inflammation Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of pd-L1 expression by nf-\u03bab in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1423170","article-title":"Pd-L1 expression is regulated by both DNA methylation and nf-kb during emt signaling in non-small cell lung carcinoma","volume":"7","author":"Asgarova","year":"2018","journal-title":"OncoImmunology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nri2262","article-title":"Treatment strategies for allergy and asthma","volume":"8","author":"Holgate","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drudis.2015.07.010","article-title":"Allergy immunotherapy: the future of allergy treatment","volume":"21","author":"Larsen","year":"2016","journal-title":"Drug Discov Today"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/all.14078","article-title":"Recent developments and highlights in immune monitoring of allergen immunotherapy","volume":"74","author":"van Zelm","year":"2019","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13223-020-00436-y","article-title":"Towards definitive management of allergic rhinitis: best use of new and established therapies","volume":"16","author":"Hossenbaccus","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.08.009","article-title":"Biologics for allergic and immunologic diseases","volume":"150","author":"Morita","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.01.017","article-title":"Targeting alarmins in asthma: from bench to clinic","volume":"155","author":"Akenroye","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"Jak inhibitors in the treatment of atopic dermatitis","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.01.020","article-title":"Oral janus kinase inhibitors for atopic dermatitis","volume":"130","author":"Mikhaylov","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.09.016","article-title":"Early il-10 producing B-cells and coinciding th\/tr17 shifts during three year grass-pollen ait","volume":"36","author":"Zissler","year":"2018","journal-title":"EBioMedicine"},{"key":"B107","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaci.2022.01.016","article-title":"Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma","volume":"149","author":"Shamji","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/all.12608","article-title":"Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge","volume":"70","author":"Scadding","year":"2015","journal-title":"Allergy"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901379","article-title":"Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation","volume":"184","author":"M\u00f6bs","year":"2010","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jaci.2008.03.013","article-title":"Grass pollen immunotherapy induces foxp3-expressing cd4+Cd25+ Cells in the nasal mucosa","volume":"121","author":"Radulovic","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/J.1365-2222.2010.03462.X","article-title":"Sublingual grass pollen immunotherapy is associated with increases in sublingual foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin a and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells","volume":"40","author":"Scadding","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"B112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12519-011-0242-3","article-title":"Dendritic cells modifi cation during sublingual immunotherapy in children with allergic symptoms to house dust mites","volume":"7","author":"Angelini","year":"2011","journal-title":"World J Pediatr"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of il-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/all.13262","article-title":"Eaaci guidelines on allergen immunotherapy: hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/all.16491","article-title":"Six injections of modified adjuvanted pq grass is effective and well-tolerated in a pivotal phase iii trial","author":"Zielen","year":"2025","journal-title":"Allergy"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the immune tolerance network impact trial): A randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101136","article-title":"Efficacy and Safety of Sq House Dust Mite Sublingual Immunotherapy-Tab let (12 Sq-Hdm) in Children with Allergic Rhinitis\/Rhinoconjunctivitis with or without Asthma (Mt-12): A Randomised, Double-Blind, Placebo-Controlled, Phase Iii Trial","volume":"48","author":"Schuster","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01826","article-title":"Predicting success of allergen-specific immunotherapy","volume":"11","author":"Zissler","year":"2020","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep03153","article-title":"Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2","volume":"3","author":"Okubo","year":"2013","journal-title":"Sci Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3030","article-title":"Tnf receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat Rev Drug Discov 2010 9:6"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/all.14716","article-title":"Comprehensive mapping of immune tolerance yields a regulatory tnf receptor 2 signature in a murine model of successful fel D 1-specific immunotherapy using high-dose cpg adjuvant","volume":"76","author":"Leonard","year":"2021","journal-title":"Allergy"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00409.2016","article-title":"Impaired tnf\/tnfr2 signaling enhances th2 and th17 polarization and aggravates allergic airway inflammation","volume":"313","author":"Li","year":"2017","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1159\/000493583","article-title":"Tnf-tnfr2 signaling inhibits th2 and th17 polarization and alleviates allergic airway inflammation","volume":"178","author":"Peng","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156311","article-title":"A tnfr2-agonist facilitates high purity expansion of human low purity treg cells","volume":"11","author":"He","year":"2016","journal-title":"PloS One"},{"key":"B126","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.1038\/s41598-023-40925-9","article-title":"Bivalent structure of a tnfr2-selective and agonistic tnf-\u03b1 Mutein fc-fusion protein enhances the expansion activity of regulatory T cells","volume":"13","author":"Inoue","year":"2023","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149498","article-title":"An immunocytokine consisting of a tnfr2 agonist and tnfr2 scfv enhances the expansion of regulatory T cells through tnfr2 clustering","volume":"697","author":"Inoue","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi8472","article-title":"In vivo reprogramming of pathogenic lung tnfr2+ Cdc2s by ifn\u03b2 Inhibits hdm-induced asthma","volume":"6","author":"Mansouri","year":"2021","journal-title":"Sci Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41385-020-0254-1","article-title":"Lung ifnar1hi tnfr2+ Cdc2 promotes lung regulatory T cells induction and maintains lung mucosal tolerance at steady state","volume":"13","author":"Mansouri","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111736","article-title":"Redistribution of tnf receptor 1 and 2 expression on immune cells in patients with bronchial asthma","volume":"11","author":"Alshevskaya","year":"2022","journal-title":"Cells"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.5414\/alx02430e","article-title":"Diagnosis and treatment of hymenoptera venom allergy: S2k guideline of the german society of allergology and clinical immunology (Dgaki) in collaboration with the arbeitsgemeinschaft f\u00fcr berufs- und umweltdermatologie E.V. (Abd), the medical association of german allergologists (Aeda), the german society of dermatology (Ddg), the german society of oto-rhino-laryngology, head and neck surgery (Dghnokc), the german society of pediatrics and adolescent medicine (Dgkj), the society for pediatric allergy and environmental medicine (Gpa), german respiratory society (Dgp), and the Austrian society for allergy and immunology (\u00d6gai)","volume":"7","author":"Ru\u00ebff","year":"2023","journal-title":"Allergol Select"},{"key":"B132","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/s41467-024-54684-2","article-title":"Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study","volume":"15","author":"Pogorelov","year":"2024","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-008-8075-4","article-title":"Bcl-3, a multifaceted modulator of nf-\u03bab-mediated gene transcription","volume":"42","author":"Palmer","year":"2008","journal-title":"Immunologic Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847699","article-title":"Bcl-3: A double-edged sword in immune cells and inflammation","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba6087","article-title":"Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma","volume":"5","author":"Seumois","year":"2020","journal-title":". Sci Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/all.16001","article-title":"Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy","volume":"79","author":"Wipperman","year":"2024","journal-title":". Allergy"},{"key":"B137","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1398-9995.2007.01526.x","article-title":"The functional insufficiency of human cd4+Cd25high T-regulatory cells in allergic asthma is subjected to tnf-\u03b1 Modulation","volume":"63","author":"Lin","year":"2008","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAAD.2004.11.022","article-title":"Infliximab in the treatment of moderate to severe atopic dermatitis","volume":"52","author":"Jacobi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMOA050580\/SUPPL_FILE\/NEJM_BERRY_697SA1.PDF","article-title":"Evidence of a role of tumor necrosis factor \u03b1 in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"New Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-tnf-\u03b1 Agents - comparison among therapeutic tnf-\u03b1 Antagonists","volume":"101","author":"Mitoma","year":"2018","journal-title":"Cytokine"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005828","article-title":"Insights into ligand binding by a viral tumor necrosis factor (Tnf) decoy receptor yield a selective soluble human type 2 tnf receptor","volume":"294","author":"Pontejo","year":"2019","journal-title":"J Biol Chem"},{"key":"B142","doi-asserted-by":"publisher","first-page":"590054","DOI":"10.3389\/fimmu.2021.590054","article-title":"Cpg adjuvant in allergen-specific immunotherapy: finding the sweet spot for the induction of immune tolerance","volume":"12","author":"Montamat","year":"2021","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba9600","article-title":"A novel tnfr2 agonist antibody expands highly potent regulatory T cells","volume":"13","author":"Torrey","year":"2020","journal-title":"Sci Signaling"},{"key":"B144","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13052-018-0519-4","article-title":"The future outlook on allergen immunotherapy in children: 2018 and beyond","volume":"44","author":"Arasi","year":"2018","journal-title":"Ital J Pediatr"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040114","article-title":"Early intervention is important to prevent sensitization to new allergens","volume":"6","author":"Terada","year":"2018","journal-title":"Med Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/all.12943","article-title":"Microbiome and its impact on gastrointestinal atopy","volume":"71","author":"Muir","year":"2016","journal-title":"Allergy"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01584","article-title":"Microbiome and allergic diseases","volume":"9","author":"Pascal","year":"2018","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2011.08.034","article-title":"Differentiation stage determines pathologic and protective allergen-specific cd4+ T-cell outcomes during specific immunotherapy","volume":"129","author":"Wambre","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.014","article-title":"Direct evidence for a critical role of cd30 in the development of allergic asthma","volume":"118","author":"Polte","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021937","article-title":"Ox40 (Cd134) controls memory T helper 2 cells that drive lung inflammation","volume":"198","author":"Salek-Ardakani","year":"2003","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.10.037","article-title":"Combination blockade of ox40l and cd30l inhibits allergen-driven memory th2 cell reactivity and lung inflammation","volume":"147","author":"Gracias","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged Efficacy of the 300ir 5-Grass Pollen Ta blet up to 2 years after Treatment Cessation, as Measured by a Recommended Daily Combined Score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"B153","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"Sq-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 Years of Treatment with Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years among Patients with Moderate to Severe Seasonal Allergic Rhinitis: The Grass Randomized Clinical Trial","volume":"317","author":"Scadding","year":"2017","journal-title":"JAMA"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/all.13138","article-title":"Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an eaaci position paper","volume":"72","author":"Shamji","year":"2017","journal-title":"Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:12:14Z","timestamp":1750306334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":156,"alternative-id":["10.3389\/fimmu.2025.1613719"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1613719","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1613719"}}